{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:20:10Z","timestamp":1773339610454,"version":"3.50.1"},"reference-count":42,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2012,4,16]]},"DOI":"10.4161\/hv.19109","type":"journal-article","created":{"date-parts":[[2012,5,2]],"date-time":"2012-05-02T21:15:53Z","timestamp":1335993353000},"page":"425-430","source":"Crossref","is-referenced-by-count":19,"title":["Subcutaneous immunization with recombinant adenovirus expressing influenza A nucleoprotein protects mice against lethal viral challenge"],"prefix":"10.1080","volume":"8","author":[{"given":"Anwar","family":"Hashem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bozena","family":"Jaentschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Gravel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Tocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracey","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Rosu-Myles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runtao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,10,27]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1016\/j.vaccine.2005.04.047","article-title":"Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein","volume":"23","author":"Epstein","year":"2005","journal-title":"Vaccine"},{"key":"R2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3201\/eid1204.051020","article-title":"Prospects for universal influenza virus vaccine","volume":"12","author":"Gerhard","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"R3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.7326\/0003-4819-123-7-199510010-00008","article-title":"The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature","volume":"123","author":"Gross","year":"1995","journal-title":"Ann Intern Med"},{"key":"R4","first-page":"1","article-title":"Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Smith","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"R5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1146\/annurev.genet.36.052402.152757","article-title":"Genetics of influenza viruses","volume":"36","author":"Steinhauer","year":"2002","journal-title":"Annu Rev Genet"},{"key":"R6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/jac\/44.suppl_2.3","article-title":"Epidemiology and pathogenesis of influenza","volume":"44","author":"Zambon","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"R7","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1086\/375056","article-title":"Pandemic influenza and the global vaccine supply","volume":"36","author":"Fedson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/498980","article-title":"Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature","volume":"193","author":"Epstein","year":"2006","journal-title":"J Infect Dis"},{"key":"R9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1590\/S0100-879X1999000200009","article-title":"Immunological properties of gene vaccines delivered by different routes","volume":"32","author":"Oliveira","year":"1999","journal-title":"Braz J Med Biol Res"},{"key":"R10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/028418699431375","article-title":"Immunogenetic properties of genes","volume":"38","author":"Wahren","year":"1999","journal-title":"Acta Oncol"},{"key":"R11","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0264-410X(00)00474-6","article-title":"DNA vaccination against respiratory influenza virus infection","volume":"19","author":"Wong","year":"2001","journal-title":"Vaccine"},{"key":"R12","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3201\/eid0805.010476","article-title":"DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice","volume":"8","author":"Epstein","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"R13","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.vaccine.2005.08.091","article-title":"Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge","volume":"24","author":"Breathnach","year":"2006","journal-title":"Vaccine"},{"key":"R14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0264-410X(96)00268-X","article-title":"Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination","volume":"15","author":"Donnelly","year":"1997","journal-title":"Vaccine"},{"key":"R15","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1128\/JVI.02335-08","article-title":"Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus","volume":"83","author":"Laddy","year":"2009","journal-title":"J Virol"},{"key":"R16","doi-asserted-by":"crossref","first-page":"e9812","DOI":"10.1371\/journal.pone.0009812","article-title":"Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret","volume":"5","author":"Rao","year":"2010","journal-title":"PLoS One"},{"key":"R17","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1016\/j.vaccine.2009.03.023","article-title":"Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses","volume":"27","author":"Patel","year":"2009","journal-title":"Vaccine"},{"key":"R18","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1128\/JVI.70.9.6119-6125.1996","article-title":"Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery","volume":"70","author":"Pertmer","year":"1996","journal-title":"J Virol"},{"key":"R19","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1128\/JVI.71.4.2715-2721.1997","article-title":"Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization","volume":"71","author":"Fu","year":"1997","journal-title":"J Virol"},{"key":"R20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"key":"R21","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza A viruses","volume":"333","author":"Ekiert","year":"2011","journal-title":"Science"},{"key":"R22","doi-asserted-by":"crossref","first-page":"e3942","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells","volume":"3","author":"Throsby","year":"2008","journal-title":"PLoS One"},{"key":"R23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"R24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nprot.2009.200","article-title":"A simple slot blot for the detection of virtually all subtypes of the influenza A viral hemagglutinins using universal antibodies targeting the fusion peptide","volume":"5","author":"Li","year":"2010","journal-title":"Nat Protoc"},{"key":"R25","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1016\/j.vaccine.2008.09.015","article-title":"Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins","volume":"26","author":"Chun","year":"2008","journal-title":"Vaccine"},{"key":"R26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbrc.2010.11.030","article-title":"Universal antibodies against the highly conserved influenza fusion peptide cross-neutralize several subtypes of influenza A virus","volume":"403","author":"Hashem","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"R27","doi-asserted-by":"crossref","DOI":"10.3791\/2784","article-title":"Quantitative analyses of all influenza type A viral hemagglutinins and neuraminidases using universal antibodies in simple slot blot assays","author":"Gravel","year":"2011","journal-title":"J Vis Exp"},{"key":"R28","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1016\/j.vaccine.2010.06.075","article-title":"Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences","volume":"28","author":"Gravel","year":"2010","journal-title":"Vaccine"},{"key":"R29","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/nm1210-1389","article-title":"Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine","volume":"16","author":"Nabel","year":"2010","journal-title":"Nat Med"},{"key":"R30","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"MBio"},{"key":"R31","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1128\/JVI.72.7.5648-5653.1998","article-title":"Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA","volume":"72","author":"Ulmer","year":"1998","journal-title":"J Virol"},{"key":"R32","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.4049\/jimmunol.181.6.4168","article-title":"A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus","volume":"181","author":"Carragher","year":"2008","journal-title":"J Immunol"},{"key":"R33","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1586\/erv.09.29","article-title":"Strategies to overcome host immunity to adenovirus vectors in vaccine development.","volume":"8","author":"Thacker","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"R34","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/jgm.1332","article-title":"Adenovirus type 5 with modified hexons induces robust transgene-specific immune responses in mice with pre-existing immunity against adenovirus type 5","volume":"11","author":"Abe","year":"2009","journal-title":"J Gene Med"},{"key":"R35","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.gt.3303085","article-title":"Significant alterations of biodistribution and immune responses in Balb\/c mice administered with adenovirus targeted to CD40(+) cells","volume":"15","author":"Huang","year":"2008","journal-title":"Gene Ther"},{"key":"R36","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.4049\/jimmunol.172.10.6290","article-title":"Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity","volume":"172","author":"Barouch","year":"2004","journal-title":"J Immunol"},{"key":"R37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.virusres.2011.09.031","article-title":"Sequential administration of bovine and human adenovirus vectors to overcome vector immunity in an immunocompetent mouse model of breast cancer","volume":"163","author":"Tandon","year":"2011","journal-title":"Virus Res"},{"key":"R38","doi-asserted-by":"crossref","first-page":"e21937","DOI":"10.1371\/journal.pone.0021937","article-title":"Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in mice","volume":"6","author":"Soboleski","year":"2011","journal-title":"PLoS One"},{"key":"R39","doi-asserted-by":"crossref","first-page":"10078","DOI":"10.1128\/JVI.77.18.10078-10087.2003","article-title":"Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system","volume":"77","author":"Lemiale","year":"2003","journal-title":"J Virol"},{"key":"R40","doi-asserted-by":"crossref","first-page":"e8350","DOI":"10.1371\/journal.pone.0008350","article-title":"Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases","volume":"4","author":"Hashem","year":"2009","journal-title":"PLoS One"},{"key":"R41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.taap.2011.03.019","article-title":"The effect of interferon-\u03b1 on the expression of cytochrome P450 3A4 in human hepatoma cells","volume":"253","author":"Flaman","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"R42","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1084\/jem.184.4.1555","article-title":"Gene vaccination with naked plasmid DNA: mechanism of CTL priming","volume":"184","author":"Corr","year":"1996","journal-title":"J Exp Med"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.4161\/hv.19109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T01:15:10Z","timestamp":1594084510000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/abs\/10.4161\/hv.19109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,16]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,10,27]]},"published-print":{"date-parts":[[2012,4,16]]}},"alternative-id":["10.4161\/hv.19109"],"URL":"https:\/\/doi.org\/10.4161\/hv.19109","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,16]]}}}